Literature DB >> 20436978

Comparison of antipyretic effectiveness of equal doses of rectal and oral acetaminophen in children.

Sedigha Akhavan Karbasi1, Moneyreh Modares-Mosadegh, Motahhareh Golestan.   

Abstract

OBJECTIVE: To compare a dose of oral and rectal acetaminophen and to evaluate acceptability of rectal acetaminophen, since oral and rectal acetaminophen is widely used as an antipyretic agent in febrile children and the comparative effectiveness of these two preparations is not well established.
METHODS: In this prospective parallel group designed study, 60 children who presented to the emergency department or outpatient pediatric clinic at a tertiary hospital and aged from 6 months to 6 years with rectal temperature over 39 degrees C were enrolled. Patients were randomly assigned to two equal-sized groups. Group 1 received 15 mg/kg acetaminophen rectally and group 2 received the same dose orally. Temperature was recorded at baseline and 1 and 3 hours after drug administration.
RESULTS: In the first group, mean decrease in temperature, 1 and 3 hours after administration of acetaminophen was 1.07+/-0.16 (p < 0.001) and 1.74+/-0.25 degrees C (p < 0.001), respectively, and in the second group it was 1.98+/-0.19 (p < 0.001) and 1.70+/-0.14 degrees C (p < 0.001), respectively (p > 0.05).
CONCLUSION: Rectal and oral acetaminophen preparations have equal antipyretic effectiveness in children. The rectal route proved to be as acceptable as the oral one among parents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436978     DOI: 10.2223/JPED.1992

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  8 in total

Review 1.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

2.  Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial.

Authors:  Houman Hashemian; Marzie Fallah Khodadoost
Journal:  Caspian J Intern Med       Date:  2021-03

Review 3.  Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: a systematic review with citation tracking.

Authors:  Jasmine Cendejas-Hernandez; Joshua T Sarafian; Victoria G Lawton; Antara Palkar; Lauren G Anderson; Vincent Larivière; William Parker
Journal:  Eur J Pediatr       Date:  2022-02-17       Impact factor: 3.860

4.  Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department.

Authors:  Firjeeth C Paramba; Vamanjore A Naushad; Nishan Purayil; Osama H Mohammed; Prem Chandra
Journal:  Ther Clin Risk Manag       Date:  2013-10-03       Impact factor: 2.423

5.  Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children.

Authors:  Benjamin Okereke; Okezie Ibeleme; Adaobi Bisi-Onyemaechi
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

Review 6.  Management of acute fever in children: Consensus recommendations for community and primary healthcare providers in sub-Saharan Africa.

Authors:  Robin Green; David Webb; Prakash Mohan Jeena; Mike Wells; Nadia Butt; Jimmy Mapenzi Hangoma; Rajatheran Sham Moodley; Jackie Maimin; Margreet Wibbelink; Fatima Mustafa
Journal:  Afr J Emerg Med       Date:  2021-04-10

7.  Aggressive antipyretics in central nervous system malaria: Study protocol of a randomized-controlled trial assessing antipyretic efficacy and parasite clearance effects (Malaria FEVER study).

Authors:  Moses B Chilombe; Michael P McDermott; Karl B Seydel; Manoj Mathews; Musaku Mwenechanya; Gretchen L Birbeck
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

8.  Rectal Diclofenac Versus Rectal Paracetamol: Comparison of Antipyretic Effectiveness in Children.

Authors:  Mohammad Reza Sharif; Mostafa Haji Rezaei; Marzieh Aalinezhad; Golbahareh Sarami; Masoud Rangraz
Journal:  Iran Red Crescent Med J       Date:  2016-01-13       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.